James Jogerst
Corporate Officer/Principal at RUBIUS THERAPEUTICS
Profile
James Jogerst is currently the Chief Business Officer at Rubius Therapeutics, Inc. Prior to this, he worked as the Vice President-Corporate Development at Adare Pharma Solutions, Inc. from 2015 to 2017.
Jogerst holds an MBA from Pepperdine University and an undergraduate degree from the University of North Texas.
James Jogerst active positions
Companies | Position | Start |
---|---|---|
RUBIUS THERAPEUTICS | Corporate Officer/Principal | 2021-08-29 |
Former positions of James Jogerst
Companies | Position | End |
---|---|---|
Adare Pharma Solutions, Inc.
Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | 2016-12-31 |
Training of James Jogerst
Pepperdine University | Masters Business Admin |
University of North Texas | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Adare Pharma Solutions, Inc.
Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- James Jogerst